In December 2015, Pharma 5 launched the first 100% Moroccan C-hepatitis drug: «SSB® 400 » made of Sofosbuvir.
This new drug belongs to the last generation of direct-action antivirals, that will allow affordable and definitive treatment of more than 625,000 Moroccans with C-hepatitis disease. The affordability of this revolutionary drug also allows to contemplate full eradication of C-hepatitis is Morocco, in accordance with the ambition set by the national health authorities.

In March 2016, (three months after the launch of SSB® 400), Pharma 5 pursued its involvement in the struggle against C-hepatitis in Morocco with the launch of the complementary treatments required to the complete, fast and efficient treatment of the main C-hepatitis genotypes registered in Morocco.

Read more . . .


In October 2017, Pharma 5 launched ” Tefovir® Pharma 5″: the first generic 100% Moroccan for the treatment of B-hepatitis
The new drug is available nationwide at a price 10 times cheaper than the brand-name drug (less than 300,00 Dirhams per box) and in compliance with the highest international quality, safety and efficiency standards.

Based on Tenofovir Disoproxil Fumarate, Tefovir® Pharma 5 is indicated for the treatment of chronic B-hepatitis for adult patients and adolescents aged from 12 to less than 18 years old.

Read more . . .